Capstone Asset Management’s Cigna CI Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2017
Q2
$4.76M Buy
28,464
+3,116
+12% +$501K 0.13% 185
2017
Q1
$3.71M Sell
25,348
-1,160
-4% -$171K 0.1% 233
2016
Q4
$3.54M Sell
26,508
-2,556
-9% -$334K 0.1% 240
2016
Q3
$3.79M Sell
29,064
-878
-3% -$115K 0.11% 221
2016
Q2
$3.83M Buy
29,942
+1,540
+5% +$203K 0.12% 205
2016
Q1
$3.9M Buy
28,402
+670
+2% +$92K 0.11% 225
2015
Q4
$4.06M Buy
27,732
+7,099
+34% +$976K 0.12% 216
2015
Q3
$2.79M Buy
20,633
+344
+2% +$49.9K 0.09% 293
2015
Q2
$3.29M Buy
20,289
+859
+4% +$119K 0.09% 277
2015
Q1
$2.52M Buy
19,430
+880
+5% +$102K 0.07% 327
2014
Q4
$1.91M Sell
18,550
-3,100
-14% -$306K 0.06% 391
2014
Q3
$1.96M Buy
21,650
+280
+1% +$26.2K 0.07% 339
2014
Q2
$1.97M Sell
21,370
-5,592
-21% -$480K 0.06% 351
2014
Q1
$2.26M Sell
26,962
-5,310
-16% -$437K 0.07% 332
2013
Q4
$2.82M Sell
32,272
-16,511
-34% -$1.35M 0.08% 280
2013
Q3
$3.75M Buy
48,783
+534
+1% +$41.7K 0.09% 247
2013
Q2
$3.5M Buy
+48,249
New +$3.25M 0.09% 237

Other funds holding CI

Capstone Asset Management's CI Position: Q2 2017 in Review

Capstone Asset Management increased its Cigna (CI) stake by 12% in Q2 2017, buying an estimated $501K and bringing the position to 28,464 shares worth $4.76M. The position accounts for 0.13% of the portfolio, ranked #185.

Capstone Asset Management first reported a position in CI in Q2 2013 and has held it in 17 quarters since. 776 funds tracked by Wall St. Rank hold CI as of Q2 2017.

  • Capstone Asset Management held 28,464 shares of Cigna worth $4.76M as of Q2 2017.
  • Capstone Asset Management bought 3,116 Cigna shares in Q2 2017, an estimated $501K.
  • Cigna made up 0.13% of Capstone Asset Management's portfolio in Q2 2017, its #185 holding.
  • Capstone Asset Management first reported a position in Cigna in Q2 2013 and has held it in 17 quarters since.
  • 776 funds tracked by Wall St. Rank held Cigna as of Q2 2017.

Based on Capstone Asset Management's 13F filing for Q2 2017, filed 10 Jul 2017.